François Bénard Selected Research

Bradykinin B1 Receptor

1/2017	Radiolabeled R954 Derivatives for Imaging Bradykinin B1 Receptor Expression with Positron Emission Tomography.
1/2016	Radiolabeled B9958 Derivatives for Imaging Bradykinin B1 Receptor Expression with Positron Emission Tomography: Effect of the Radiolabel-Chelator Complex on Biodistribution and Tumor Uptake.
8/2015	Imaging Bradykinin B1 Receptor with 68Ga-Labeled [des-Arg10]Kallidin Derivatives: Effect of the Linker on Biodistribution and Tumor Uptake.
4/2015	Comparative studies of three 68Ga-labeled [Des-Arg10]kallidin derivatives for imaging bradykinin B1 receptor expression with PET.
3/2015	(18)F-trifluoroborate derivatives of [des-arg(10)]kallidin for imaging bradykinin b1 receptor expression with positron emission tomography.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

François Bénard Research Topics

Disease

59	Neoplasms (Cancer) 06/2022 - 01/2002
26	Prostatic Neoplasms (Prostate Cancer) 03/2022 - 06/2005
14	Breast Neoplasms (Breast Cancer) 12/2019 - 08/2002
8	Melanoma (Melanoma, Malignant) 09/2020 - 01/2017
6	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2005
3	Hodgkin Disease (Hodgkin's Disease) 01/2021 - 08/2003
3	Lymphoma (Lymphomas) 01/2018 - 01/2002
3	Heart Failure 11/2014 - 10/2003
2	Infections 01/2022 - 01/2012
2	Inflammation (Inflammations) 08/2020 - 03/2015
2	Hypoxia (Hypoxemia) 01/2018 - 01/2017
2	Cardiotoxicity 11/2014 - 02/2012
2	Carcinoma (Carcinomatosis) 10/2010 - 05/2007
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021
1	Chronic Pain 08/2020
1	Obesity 08/2020
1	Glioma (Gliomas) 07/2019

Drug/Important Bio-Agent (IBA)

15	AntigensIBA 03/2022 - 01/2018
15	Peptides (Polypeptides)IBA 01/2022 - 08/2011
9	Bombesin Receptors (Bombesin Receptor)IBA 06/2022 - 04/2008
7	Type 1 Melanocortin ReceptorIBA 01/2022 - 01/2017
7	Biomarkers (Surrogate Marker)IBA 12/2019 - 10/2009
6	LigandsIBA 01/2020 - 01/2005
6	Estrogen ReceptorsIBA 01/2012 - 08/2004
5	BombesinIBA 03/2022 - 04/2008
5	Melanocyte-Stimulating Hormones (MSH)IBA 05/2020 - 01/2017
5	Bradykinin B1 ReceptorIBA 01/2017 - 03/2015
5	Hormones (Hormone)IBA 05/2007 - 08/2004
4	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 06/2022 - 04/2015
4	AcidsIBA 01/2022 - 01/2017
4	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2021 - 02/2010
4	Chelating AgentsIBA 01/2021 - 08/2011
4	AlbuminsIBA 01/2021 - 04/2006
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2006 - 08/2003
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2005
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 02/2012
3	Radioisotopes (Radionuclides)IBA 01/2020 - 01/2017
3	MetalsIBA 01/2020 - 08/2012
3	Amino Acids FDA Link 07/2019 - 04/2003
3	Acetates (Acetic Acid Esters)FDA Link 11/2018 - 07/2008
3	Carbonic Anhydrase IXIBA 01/2017 - 09/2015
3	EnzymesIBA 03/2016 - 01/2005
3	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 05/2007
3	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 08/2012 - 08/2011
2	Trastuzumab (Herceptin)FDA Link 06/2022 - 01/2021
2	2- (3- (1- carboxy- 5- ((6- fluoropyridine- 3- carbonyl)amino)pentyl)ureido)pentanedioic acidIBA 01/2022 - 11/2019
2	enzalutamideIBA 10/2021 - 03/2018
2	Glutamic Acid (Glutamate)FDA Link 01/2021 - 01/2019
2	177Lu-PSMA-617IBA 01/2021 - 11/2018
2	Sodium Glutamate (Accent)IBA 01/2021 - 12/2018
2	IsotopesIBA 05/2020 - 01/2018
2	Prostate-Specific Antigen (Semenogelase)IBA 11/2019 - 05/2007
2	Integrin alpha4beta1 (VLA-4)IBA 01/2019 - 01/2018
2	gallium 68 PSMA-11IBA 12/2018 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2017 - 10/2010
2	Complement System Proteins (Complement)IBA 01/2017 - 01/2005
2	Phenobarbital (Luminal)FDA Link 01/2017 - 10/2009
2	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2017 - 09/2014
2	Acetazolamide (Diamox)FDA LinkGeneric 03/2016 - 09/2015
2	KallidinIBA 08/2015 - 01/2015
2	acetoacetic acid (acetoacetate)IBA 11/2014 - 07/2008
2	KetonesIBA 11/2014 - 07/2008
2	A-factor (Streptomyces)IBA 08/2012 - 04/2008
2	Estradiol (Delestrogen)FDA LinkGeneric 01/2012 - 04/2007
2	AndrogensIBA 04/2006 - 06/2005
2	RadiopharmaceuticalsIBA 08/2004 - 08/2002
1	bombesin (7-14)IBA 06/2022
1	4,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA 06/2022
1	SodiumIBA 01/2022
1	Epoxy Resins FDA Link 01/2022
1	abirateroneIBA 10/2021
1	Dacarbazine (DIC)FDA LinkGeneric 01/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Lysine (L-Lysine)FDA Link 01/2021
1	KininsIBA 08/2020
1	NucleosidesIBA 05/2020
1	ThymidineIBA 05/2020
1	Cystine (L-Cystine)IBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2019
1	diethyl maleateIBA 12/2019
1	Glutathione (Reduced Glutathione)IBA 12/2019
1	CXC ChemokinesIBA 11/2019
1	LY2510924IBA 11/2019
1	pyridineIBA 11/2019
1	Branched-Chain Amino AcidsIBA 07/2019
1	Glycoproteins (Glycoprotein)IBA 12/2018
1	Phosphates (Orthophosphate)IBA 12/2018
1	BuffersIBA 11/2018
1	IntegrinsIBA 01/2018
1	PSMA-617IBA 01/2018

Therapy/Procedure

18	Therapeutics 06/2022 - 08/2003
6	Radiotherapy 03/2022 - 01/2016
6	Drug Therapy (Chemotherapy) 01/2021 - 01/2005
5	Precision Medicine 01/2022 - 01/2017
3	Prostatectomy (Retropubic Prostatectomy) 03/2022 - 02/2007
3	Castration 10/2021 - 03/2018
1	Brachytherapy 01/2022